Exposing the Molecular Screening Method of Indonesian Natural Products Derivate as Drug Candidates for Cervical Cancer

The menace of cervical cancer has reached an alarming rate. There are more than 450.000cases of cervical cancer yearly, with mortality rate of about 50%. This deadly cancer is causedby human papillomavirus (HPV), mainly subtypes 16 and 18. The pharmaceutical industryhas produced drug for combating the virus, known as SAHA (suberoylanilide hydroxamicacid). It inhibits class II HDAC Homo sapiens (HDACi). The utilization of SAHA has someside effects, one of which is bone loss. Thus, searching for viable alternatives aside SAHA isinevitable. The objective of this research is to investigate the molecular interaction of selectedIndonesian natural products with class II HDAC Homo sapiens. LigX tool in MOE 2008.10was used as an instrument to investigate the molecular interaction. Then, computer-aided drugdiscovery and development (CADDD) approach involving molecular docking and dynamicsmethods was utilized to screen the natural products library. In the end, we found that herbaricacid could act as a potential drug candidate for cervical cancer.